Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-10

FDA Approved: PRALATREXATE — Original Application (Dr.Reddy's Laboratories Inc.,)

View source ↗

Summary

FDA approved an Original Application for pralatrexate by Dr. Reddy's Laboratories Inc., enabling a generic version of the anti-cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pralatrexate (pralatrexate)

Snippet

ORIG AP for PRALATREXATE (PRALATREXATE)